Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Gerhard

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Focus (American Psychiatric Publishing)|September 6, 2021
Mortality Risk of Antipsychotic Augmentation for Adult DepressionTobias Gerhard, T Scott Stroup, Christoph U Correll, et al.
Plos One|September 30, 2020
Mortality risk of antipsychotic augmentation for adult depressionTobias Gerhard, T Scott Stroup, Christoph U Correll, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 31, 2016
Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-AnalysisSu Young Park, Chiara Cervesi, Britta Galling, et al.
JAMA Psychiatry|October 15, 2025
Stimulant Use Disorder Diagnoses in Adolescent and Young Adult Medicaid EnrolleesGreta Bushnell, Katherine M Keyes, Yuyang Zhu, et al.
Pediatrics|October 8, 2014
Adherence to guidelines for glucose assessment in starting second-generation antipsychoticsMarsha A Raebel, Robert Penfold, Ann W McMahon, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
Design considerations in an active medical product safety monitoring systemJoshua J Gagne, Bruce Fireman, Patrick B Ryan, et al.
BMC Medical Research Methodology|August 8, 2012
Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapyTobias Gerhard, Joseph Ac Delaney, Rhonda M Cooper-Dehoff, et al.
Pharmacoepidemiology and Drug Safety|June 8, 2021
Risk of clinically relevant hyperglycemia with metoprolol compared to carvedilol in older adults with heart failure and diabetesChintan V Dave, Brian L Strom, Fred A Kobylarz, et al.
Clinical Cardiology|February 16, 2006
Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgeryThomas M Beaver, Almut G Winterstein, Jonathan J Shuster, et al.
JAMA Network Open|April 8, 2022
Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic AgentsRishi J Desai, Vijay R Varma, Tobias Gerhard, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Focus (American Psychiatric Publishing)|September 6, 2021
Mortality Risk of Antipsychotic Augmentation for Adult DepressionTobias Gerhard, T Scott Stroup, Christoph U Correll, et al.
Plos One|September 30, 2020
Mortality risk of antipsychotic augmentation for adult depressionTobias Gerhard, T Scott Stroup, Christoph U Correll, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 31, 2016
Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-AnalysisSu Young Park, Chiara Cervesi, Britta Galling, et al.
JAMA Psychiatry|October 15, 2025
Stimulant Use Disorder Diagnoses in Adolescent and Young Adult Medicaid EnrolleesGreta Bushnell, Katherine M Keyes, Yuyang Zhu, et al.
Pediatrics|October 8, 2014
Adherence to guidelines for glucose assessment in starting second-generation antipsychoticsMarsha A Raebel, Robert Penfold, Ann W McMahon, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
Design considerations in an active medical product safety monitoring systemJoshua J Gagne, Bruce Fireman, Patrick B Ryan, et al.
BMC Medical Research Methodology|August 8, 2012
Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapyTobias Gerhard, Joseph Ac Delaney, Rhonda M Cooper-Dehoff, et al.
Pharmacoepidemiology and Drug Safety|June 8, 2021
Risk of clinically relevant hyperglycemia with metoprolol compared to carvedilol in older adults with heart failure and diabetesChintan V Dave, Brian L Strom, Fred A Kobylarz, et al.
Clinical Cardiology|February 16, 2006
Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgeryThomas M Beaver, Almut G Winterstein, Jonathan J Shuster, et al.
JAMA Network Open|April 8, 2022
Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic AgentsRishi J Desai, Vijay R Varma, Tobias Gerhard, et al.
Pageof 10